Search
Close this search box.

Pfizer, US Ink $5.29B Deal For Possible Covid-19 Treatment

This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP)

The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation’s largest purchase agreement yet for a coronavirus therapy.

Pfizer asked the Food and Drug Administration on Tuesday to authorize emergency use of the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections.

The FDA is already reviewing a competing pill from Merck and will hold a public meeting on it later this month.

The price for Pfizer’s potential treatment amounts to about $529 per course. The U.S. has already agreed to pay roughly $700 per course of Merck’s drug for about 3.1 million treatments.

Pfizer said Thursday the price being paid by the U.S. government reflects the high number of treatment courses purchased through 2022.

President Joe Biden said in a statement that his administration is taking steps to ensure that the treatments “will be easily accessible and free.”

“This treatment could prove to be another critical tool in our arsenal that will accelerate our path out of the pandemic,” Biden said, adding that vaccines protecting against the virus remain the strongest tool.

Pfizer has started rolling submissions for approval in several other countries and there are advanced purchase agreements with other governments as well.

On Tuesday, Pfizer signed a deal a with U.N.-backed group to allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.

Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19.

The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity.

Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That’s similar to how other drugs are currently used to treat the disease.

But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.

Pfizer’s potential treatment is taken twice a day for five days, in combination with a second antiviral pill that boosts its effect.

Pfizer has already booked more than $24 billion in global revenue so far this year from Comirnaty, its COVID-19 vaccine, which has quickly become the drugmaker’s top-selling product.

Shares of New York-based Pfizer Inc. climbed less than 2% at the opening bell Thursday. They hit an all-time high of $51.86 this summer, topping a previous mark that had stood for 22 years.

Pfizer and Merck are seeking approval for their treatments as COVID-19 cases start to rebound again in the U.S.

The seven-day rolling average for daily new cases approached 87,000 on Wednesday, according to data from Johns Hopkins University. That’s up from around 68,000 late last month.

(AP)



6 Responses

  1. So now they will “ban” the vaccine and “mandate” the new pill, which is just a copy of Ivermectin for 100x the price.

  2. The FDA cannot be trusted – they infamously just approved the experimental mRNA injection for children by creating an ad hoc board with new members to be certain they would get an approval. This of course, is just the tip of their iceberg.

    Of course all of this is being done at the taxpayers’ expense, not to mention the real lack of efficacy – and safety of these treatments that are also highly experimental and are being pushed through lacking objective and responsible testing and data.

  3. Enough already. The over-vaccinating and now never ending booster shots are what’s causing the variants to pop up. Vaccines should be for the elderly and those with underlying health conditions. For everyone else who is relatively healthy, you’ll likely experience flu-like symptoms at worst. Very few, percentage wise, end up in a hospital (from those who did not have other health conditions). It’s as clear as day…big pharma is pushing the hysteria. Why?? The never ending government contracts for billions. So why not make everyone think a booster shot every few months is what we must have. We’ve all been duped. It’s a big money making shake down of the american tax payer as usual (the shots aren’t “free”. It’s our tax dollars paying for it).

  4. And that’s also a reason we are suffering from inflation. The U. S. is spending all our tax dollars plus money the govt doesn’t even have, to line the pockets of these greedy (so called Dr. and scientist) Criminals. And they will not stop with their diabolical schemes until they get everybody vaccinated and boostered till their eyeballs.

Leave a Reply


Popular Posts